188 related articles for article (PubMed ID: 31744878)
1. HSF1-Mediated Control of Cellular Energy Metabolism and mTORC1 Activation Drive Acute T-Cell Lymphoblastic Leukemia Progression.
Eroglu B; Pang J; Jin X; Xi C; Moskophidis D; Mivechi NF
Mol Cancer Res; 2020 Mar; 18(3):463-476. PubMed ID: 31744878
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemia.
Kourtis N; Lazaris C; Hockemeyer K; Balandrán JC; Jimenez AR; Mullenders J; Gong Y; Trimarchi T; Bhatt K; Hu H; Shrestha L; Ambesi-Impiombato A; Kelliher M; Paietta E; Chiosis G; Guzman ML; Ferrando AA; Tsirigos A; Aifantis I
Nat Med; 2018 Aug; 24(8):1157-1166. PubMed ID: 30038221
[TBL] [Abstract][Full Text] [Related]
3. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
4. Andrographolide upregulates protein quality control mechanisms in cell and mouse through upregulation of mTORC1 function.
Dutta N; Ghosh S; Nelson VK; Sareng HR; Majumder C; Mandal SC; Pal M
Biochim Biophys Acta Gen Subj; 2021 Jun; 1865(6):129885. PubMed ID: 33639218
[TBL] [Abstract][Full Text] [Related]
5. CBAP modulates Akt-dependent TSC2 phosphorylation to promote Rheb-mTORC1 signaling and growth of T-cell acute lymphoblastic leukemia.
Chiang YJ; Liao WT; Ho KC; Wang SH; Chen YG; Ho CL; Huang SF; Shih LY; Yang-Yen HF; Yen JJ
Oncogene; 2019 Feb; 38(9):1432-1447. PubMed ID: 30266989
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia.
Laukkanen S; Veloso A; Yan C; Oksa L; Alpert EJ; Do D; Hyvärinen N; McCarthy K; Adhikari A; Yang Q; Iyer S; Garcia SP; Pello A; Ruokoranta T; Moisio S; Adhikari S; Yoder JA; Gallagher K; Whelton L; Allen JR; Jin AH; Loontiens S; Heinäniemi M; Kelliher M; Heckman CA; Lohi O; Langenau DM
Blood; 2022 Oct; 140(17):1891-1906. PubMed ID: 35544598
[TBL] [Abstract][Full Text] [Related]
7. Heat shock factor 1 is a promising therapeutic target against adult T-cell leukemia.
Ishikawa C; Mori N
Med Oncol; 2023 May; 40(6):172. PubMed ID: 37165174
[TBL] [Abstract][Full Text] [Related]
8. HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia.
Frezzato F; Raggi F; Martini V; Severin F; Trimarco V; Visentin A; Scomazzon E; Accordi B; Bresolin S; Piazza F; Facco M; Basso G; Semenzato G; Trentin L
Int J Cancer; 2019 Dec; 145(11):3089-3100. PubMed ID: 31044428
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia.
Nguyen TL; Nokin MJ; Terés S; Tomé M; Bodineau C; Galmar O; Pasquet JM; Rousseau B; van Liempd S; Falcon-Perez JM; Richard E; Muzotte E; Rezvani HR; Priault M; Bouchecareilh M; Redonnet-Vernhet I; Calvo J; Uzan B; Pflumio F; Fuentes P; Toribio ML; Khatib AM; Soubeyran P; Murdoch PDS; Durán RV
Mol Oncol; 2021 May; 15(5):1412-1431. PubMed ID: 33314742
[TBL] [Abstract][Full Text] [Related]
10. The transcriptional regulator of the chaperone response HSF1 controls hepatic bioenergetics and protein homeostasis.
Qiao A; Jin X; Pang J; Moskophidis D; Mivechi NF
J Cell Biol; 2017 Mar; 216(3):723-741. PubMed ID: 28183717
[TBL] [Abstract][Full Text] [Related]
11. DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia.
Lin S; Tian L; Shen H; Gu Y; Li JL; Chen Z; Sun X; You MJ; Wu L
Oncogene; 2013 Oct; 32(40):4845-53. PubMed ID: 23108395
[TBL] [Abstract][Full Text] [Related]
12. HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer.
Schulz R; Streller F; Scheel AH; Rüschoff J; Reinert MC; Dobbelstein M; Marchenko ND; Moll UM
Cell Death Dis; 2014 Jan; 5(1):e980. PubMed ID: 24384723
[TBL] [Abstract][Full Text] [Related]
13. mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma.
Holmes B; Benavides-Serrato A; Freeman RS; Landon KA; Bashir T; Nishimura RN; Gera J
Oncogene; 2018 Feb; 37(6):732-743. PubMed ID: 29059166
[TBL] [Abstract][Full Text] [Related]
14. Heat shock factor 1 inhibits the mitochondrial apoptosis pathway by regulating second mitochondria-derived activator of caspase to promote pancreatic tumorigenesis.
Liang W; Liao Y; Zhang J; Huang Q; Luo W; Yu J; Gong J; Zhou Y; Li X; Tang B; He S; Yang J
J Exp Clin Cancer Res; 2017 May; 36(1):64. PubMed ID: 28482903
[TBL] [Abstract][Full Text] [Related]
15. Nucleoporin TPR (translocated promoter region, nuclear basket protein) upregulation alters MTOR-HSF1 trails and suppresses autophagy induction in ependymoma.
Dewi FRP; Jiapaer S; Kobayashi A; Hazawa M; Ikliptikawati DK; Hartono ; Sabit H; Nakada M; Wong RW
Autophagy; 2021 Apr; 17(4):1001-1012. PubMed ID: 32207633
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Heat Shock Factor 1 Activity through Silencing of Ser303/Ser307 Phosphorylation Supports a Metabolic Program Leading to Age-Related Obesity and Insulin Resistance.
Jin X; Qiao A; Moskophidis D; Mivechi NF
Mol Cell Biol; 2018 Sep; 38(18):. PubMed ID: 29941492
[TBL] [Abstract][Full Text] [Related]
17. Hyperactivation of mTORC1 and mTORC2 by multiple oncogenic events causes addiction to eIF4E-dependent mRNA translation in T-cell leukemia.
Schwarzer A; Holtmann H; Brugman M; Meyer J; Schauerte C; Zuber J; Steinemann D; Schlegelberger B; Li Z; Baum C
Oncogene; 2015 Jul; 34(27):3593-604. PubMed ID: 25241901
[TBL] [Abstract][Full Text] [Related]
18. Clonal evolution enhances leukemia-propagating cell frequency in T cell acute lymphoblastic leukemia through Akt/mTORC1 pathway activation.
Blackburn JS; Liu S; Wilder JL; Dobrinski KP; Lobbardi R; Moore FE; Martinez SA; Chen EY; Lee C; Langenau DM
Cancer Cell; 2014 Mar; 25(3):366-78. PubMed ID: 24613413
[TBL] [Abstract][Full Text] [Related]
19. Control of amino acid transport coordinates metabolic reprogramming in T-cell malignancy.
Grzes KM; Swamy M; Hukelmann JL; Emslie E; Sinclair LV; Cantrell DA
Leukemia; 2017 Dec; 31(12):2771-2779. PubMed ID: 28546582
[TBL] [Abstract][Full Text] [Related]
20. The mTORC1-mediated activation of ATF4 promotes protein and glutathione synthesis downstream of growth signals.
Torrence ME; MacArthur MR; Hosios AM; Valvezan AJ; Asara JM; Mitchell JR; Manning BD
Elife; 2021 Mar; 10():. PubMed ID: 33646118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
